Phosphatidylethanolamines (PE)

LysoPE (20:4/0:0) is a lysophosphatidylethanolamine glycerophospholipid and is an endogenous metabolite.

22:6 PE is a lipid that can be used to prepare lipid nanoparticles (LNPs) for drug delivery.

1-Palmitoyl-3-oleoyl-sn-glycero-2-PE is a form of phosphatidylethanolamine (PE) which is formed primarily in the reaction of CDP-ethanolamine and diacylglycerol.

PE (P-16:0/18:2(9Z,12Z)) (PlsEtn 16:0/18:2) is a phosphatidylethanolamine that can be used as a metabolic biomarker for evaluating uterine muscle layer infiltration and Alzheimer's disease.

1-Myristoyl-2-docosahexaenoyl-sn-glycero-3-phosphatidylethanolamine is a lycerophospholipid.

LysoPE(P-16:0/0:0) is a lysophosphatidylethanolamine and metabolite. LysoPE(P-16:0/0:0) is significantly decreased in the plasma of spinal tuberculosis. LysoPE(P-16:0/0:0) can be screened as potential diagnostic biomarkers for spinal tuberculosis.

1-1(Z)-Octadecenyl-2-adrenoyl-sn-glycero-3-pe is a biochemical reagent.

1-Palmitoleoyl-2-vaccenoyl-sn-glycero-3-phosphatidylethanolamine is an ester product.

2-Aminoethyl ((R)-2,3-bis(hexadecyloxy)propyl) hydrogen phosphate is an ester product.

Glycerophospho-N-oleoyl ethanolamine (GNOE) is a serum metabolite. Glycerophospho-N-oleoyl ethanolamine can be used to study Bicuspid aortic valve (BAV) disease.